CCO’s Conference to Clinic Highlights ​From ASH 2024 Annual Meeting: Lymphomas

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
ASH 2024 Conference to Clinic: Lymphomas

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
An Expert’s Guide to ASH 2024: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Individualizing CLL Therapy: Second-Line Treatment and Beyond

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Individualizing CLL Therapy: Second-Line Treatment and Beyond

Content Format:

Slideset

Credit Type:

--

Credits:

--
Individualizing CLL Therapy: Frontline Treatment

Content Format:

Slideset

Credit Type:

--

Credits:

--
Individualizing CLL Therapy: Frontline Treatment

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Current Clinical Practice and NCCN Guidelines for CLL/SLL

Content Format:

Podcast Episodes

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
The Importance of Individualizing CLL/SLL Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Evolving Therapeutic Options in Aggressive B-Cell Lymphomas: Expert Guidance for the Community Multidisciplinary Team

Content Format:

Slideset

Credit Type:

--

Credits:

--
FAQs: Fine-tuning Contemporary Treatment for Patients With CLL/SLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Effective Management of Patients with Relapsed/Refractory CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Community Care Team Workshops: New Frontline Strategies Challenge Longtime Standards in DLBCL

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
FAQs: Incorporating Novel and Emerging Treatment Combinations Into the Management of Aggressive B-Cell Lymphomas

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
New Treatment Strategies in Aggressive B-Cell Lymphomas: Advances, Application, and a Glimpse of the Future

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.50
Selection and Sequencing of Available, New, and Emerging Agents for Relapsed/Refractory DLBCL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Community Care Team Workshops: New Frontline Strategies Challenge Longtime Standards in DLBCL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: Applying the Latest Data in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Answers to Frequently Asked Questions on State-of-the-Art Management of CLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPointsGuideline Updates and Real-World Experiences in CLL: State-of-the-Art Evidence and Next Questions

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimal Selection of Therapy for Treatment-Naive CLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Expert Insights on Highlights From ASH 2020 on Lymphomas/CLL

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Expanding Approved CAR T-Cell Therapy Treatment Options for Patients With Lymphoma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Selections From ASH 2020: Lymphomas/CLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy: FAQ

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
ExpressPoints Application of Individualized Treatment for CLL/SLL: Novel Agents, Combinations, and Sequencing Therapy

Content Format:

Slideset

Credit Type:

--

Credits:

--
Optimal Selection of Therapy for Treatment-Naive CLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Cases in CLL: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL Slides: Third-line Treatment Following BTK Inhibitor– and Venetoclax-Based Therapy

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Cases in CLL: Options for an Older Patient Requiring First-line Therapy

Content Format:

Multimedia

Credit Type:

AANP | ACPE | AMA

Credits:

0.25
Cases in CLL Slides: Options for an Older Patient Requiring First-line Therapy

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Leveraging BTK Inhibition Strategies in B-Cell Malignancies: Expert Perspectives to Guide Clinical Decisions

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Approaches to Individualized Treatment for Chronic Lymphocytic Leukemia: Expert Guidance on Sequencing Therapy, Novel Agents, and Their Combinations

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Current Treatment Algorithm for CLL and Clinical Trial Spotlight: A Resource for Clinicians

Content Format:

PDF

Credit Type:

--

Credits:

--
How I Manage Adverse Events Associated With BTK Inhibitors

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--